Related Experiment Video
Updated: Jun 11, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Beta-2 microglobulin levels in hemodialysis patients
Asim Mumtaz1, Muhammad Anees, Muhammad Bilal
1Department of Nephrology, King Edward Medical University, Lahore, Pakistan.
Beta2-microglobulin (beta2-m) levels are significantly elevated in hemodialysis patients. Low-flux dialyzers, patient age, and lower serum albumin are associated with higher beta2-m levels.
Area of Science:
- Nephrology
- Biochemistry
Background:
- Beta2-microglobulin (beta2-m) is a protein that can accumulate in patients with impaired kidney function.
- Elevated beta2-m levels are associated with various complications in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD).
Purpose of the Study:
- To determine beta2-m levels in hemodialysis patients.
- To identify factors influencing beta2-m levels in this population.
Main Methods:
- A cross-sectional study involving 50 end-stage renal disease (ESRD) patients on maintenance hemodialysis (HD).
- Collected demographic data, dialysis details (dialyzer type, membrane, dialysate), and blood samples for hematological and biochemical analysis, including beta2-m.
- Compared beta2-m levels with a control group.
Main Results:
- Hemodialysis patients exhibited significantly elevated beta2-m levels (92.6 +/- 17.1 mg/L) compared to controls (2.0 +/- 1.29 mg/L).
- The use of low-flux dialyzers was identified as the primary factor for increased beta2-m.
- Patient age and serum albumin showed a statistically significant relationship with beta2-m levels (inverse for albumin).
Conclusions:
- Beta2-microglobulin levels are markedly high in hemodialysis patients.
- Low-flux dialyzer use is a significant contributor to elevated beta2-m.
- Age and serum albumin are important factors associated with beta2-m levels in dialysis patients.
Related Concept Videos
Serum Studies: Renal Function Tests
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Hemodialysis III: Nursing Management
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Hemodialysis II: Procedure and Complications
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration